Recurrent meningiomas reveal insights into their aggressive behavior
The study opens new opportunities for future development of potential biomarkers and therapeutic agents for these challenging tumors.
Read MoreThe study opens new opportunities for future development of potential biomarkers and therapeutic agents for these challenging tumors.
Read MoreA student/mentor pair shares how the SOAR program brought them together to conduct basic science research and how the experience is shaping their careers.
Read MoreWhile the Baylor team was testing a strategy to improve heart defects associated with DM1, they uncovered an unexpected new insight into the condition.
Read MoreClinGen can be used to build evidence-based genetic testing panels, resolve discrepancies in variant classification and guide disclosure of genomic findings to patients.
Read MoreElection to the National Academy of Medicine is considered one of the highest honors that recognizes individuals for their outstanding professional achievement and commitment to service in health and medicine.
Read MoreThis is the first report of a unique metabolite profile linked to human endometriosis, bringing us closer to better ways to manage the condition.
Read MoreThe findings could reduce the illness and mortality that occur after TB has been successfully treated.
Read MoreThe researchers’ next steps include studying how DAPK3 promotes TNBC migration and assess its potential value as a therapeutic target.
Read MoreThis model can help identify new disease biomarkers and test therapies that could alter its progression, maybe even prevent the condition.
Read MoreDr. Jin Wang explains what the new Center for NextGen Therapeutics has to offer to researchers at Baylor College of Medicine, across the Texas Medical Center and beyond.
Read More